Changing tomorrow

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. 

Financial results for Q3 YTD/FY2024

Astellas announced our financial results for Q3 YTD/FY2024 on February 4th. The Presentation material, video, and meeting script are now available.

Our stories

Shaping tomorrow, together: How partnerships can unlock scientific innovation for patients

Science, collaboration and breakthroughs: Insights from Astellas' Life Sciences and West Coast Innovation Centers

test

Every day of vision loss is one too many: Addressing the impact of eye diseases

About Astellas

Astellas is headquartered in Tokyo, Japan and operates in more than 70 countries and areas around the world.

Our medicines and disease area

Astellas provides transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health

 

Our medicines and disease areas

Astellas provides transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health

 

jnjd

Careers

Astellas bring together experts from around the world and some of the brightest talent in the industry – all united in our dedication to pursuing brave ideas and ambitious outcomes.

Our medicines and disease area

Astellas provides transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health

 

Our medicines and disease areas

Astellas provides transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health